Answers are grounded in this paper and cite their sources.
Among critical events in the immediate postoperative period, ventilatory depression, airway obstruction, and aspiration of gastric contents are the three most common life-threatening anesthesia-related complications [1]. They account for more than two thirds of all critical events after an anesthetic procedure, and in most of these events the consequence for the patient is a risk of hypoxic injury [1,2]. Residual effects of anesthetics play essential roles as underlying mechanisms of postoperative ventilatory failure and hypoxia. Impaired respiratory control may be caused by depression of central ventilatory control, by depression of peripheral sensory organs, such as the carotid body chemoreceptors, or by impaired control of the pharynx and the upper airways due to muscular weakness and dyscoordination with risk for airway obstruction and aspiration. In this review, new findings concerning ventilation and residual effects of neuromuscular blocking drugs and volatile inhaled anesthetics will be put in perspective. Residual Neuromuscular Block and Ventilation Early fundamental knowledge about the effects of curare-like drugs on ventilation was discovered >150 yr ago. The British surgeon Brodie [3] showed in 1811 that lethal effects of curare in animals could be overcome, provided artificial ventilation was given. After application of curare to a small wound in his cat and by applying manual ventilation, he not only showed that the cat survived, but also described how the animal recovered gradually, starting with small respiratory efforts and continuing with gross muscle movements until the animal completely recovered after approximately 1 h. Although not concluded in this classical experiment, the author indirectly describes the different recovery pattern of respiratory and nonrespiratory muscles. The different sensitivity to muscle relaxants among central and peripheral muscle groups has been studied extensively [4-8]. In a series of human experiments under partial neuromuscular block, Gal and Smith [9] and Gal and Goldberg [10] characterized the resistance of respiratory muscles to muscle relaxants (the respiratory sparing effect) and the different sensitivity between peripheral skeletal muscles of the hand and the diaphragm. Residual neuromuscular paralysis only minimally affected tidal volumes and respiratory frequency during supine resting ventilation. Yet, resting minute ventilation was maintained at normocarbia despite considerable weakness of peripheral skeletal muscles of the hand (Figure 1). During more intense neuromuscular block with a subsequent reduction of the tidal volume, a normal minute ventilation is maintained by an increased respiratory frequency. Hence, during resting ventilation in the presence of an incomplete neuromuscular block, normocarbia is usually well maintained but at the cost of an increased work of breathing. Moreover, the ventilatory response to carbon dioxide stimulation (hypercapnic ventilatory response [HCVR]) is well maintained in the partially paralyzed awake subject. Studies on neuromuscular blocking drugs with intermediate durationsof action have confirmed this lack of depression of minute ventilation and maintained HCVR during a partial neuromuscular block [11,12]. These findings support the early observations made by Gal and Smith [9] and Gal and Goldberg [10] and demonstrate the relative resistance of central respiratory muscles, such as the diaphragm and intercostal muscles, making it possible for the partially paralyzed subject to maintain adequate minute ventilation, even during hypercapnic stimulation. More importantly, it also shows that ventilatory control during hypercarbia is unaffected, indicating that central respiratory neurons are uninfluenced by a partial neuromuscular block, which indirectly confirms the lack of blood-brain barrier transfer by these highly hydrophilic compounds [13].Figure 1: Effects of increasing doses of d-tubocurarine on ventilatory responses during controlled hypercapnia. VE = minute ventilation; VT = tidal volume; f = respiratory frequency. From Gal and Smith [9] with permission from Anesthesiology.Safe recovery from a neuromuscular block allowing tracheal extubation and institution of spontaneous breathing was facilitated by the introduction of neuromuscular monitoring techniques, i.e., after description of the train-of-four (TOF) nerve stimulus pattern [14]. After spirometry of awake volunteers receiving bolus doses of d-tubocurarine [15], Ali et al. [14] concluded that a mechanical adductor pollicis muscle TOF ratio (T4/T1 twitch ratio) of 0.70 was associated with normal respiratory function. This conclusion was based on the assumption that sustained maximal inspiratory force and minute ventilation indicated safe recovery from a neuromuscular block (Figure 2). Later, similar findings and conclusions were made for intermediate-duration drugs, such as vecuronium and atracurium [12]. Pavlin et al. [16] demonstrated, however, that despite adequate recovery of the diaphragm, there may be considerable weakness of muscles involved in the maintenance of the airway. Recently, further information has been collected concerning pharyngeal function and protection of the airway in partially paralyzed subjects [17,18]. Moreover, residual neuromuscular block is a risk factor for postoperative pulmonary complications [19]. From this important study [19], it is clear that patient outcome can be changed by using neuromuscular blocking drugs with shorter durations of action instead of those with a long recovery time profile (e.g., pancuronium) and by avoiding residual neuromuscular block. After the administration of mivacurium in subparalyzing doses [18], awake, nonanesthetized subjects were not able to control the tongue and complained of diplopia, despite almost complete recovery of the adductor pollicis muscle TOF responses above a T4/T1 ratio of 0.90. In contrast, D'Honneur et al. [20], with a limited number of subjects (n = 6), could not demonstrate changes in upper airway resistance during resting ventilation or hypercapnia-induced hyperventilation at an adductor pollicis TOF ratio of approximately 0.50 [20]. However, functional assessment of the pharynx using fluoroscopy-controlled solid-state manometry and simultaneous videoradiographical detection of aspiration revealed that recovery of neuromuscular function to allow spontaneous breathing with normal pharyngeal function requires a mechanical adductor pollicis TOF of 0.90). Data presented are mean +/- SD. TOF = train-of-four. ** = P < 0.01. Data from Eriksson [11] and Figure reprintedwith permission from Eriksson LL. Reduced hypoxic chemosensitivity in partially paralyzed man: a new property of muscle relaxants? Acta Anesthesiol Scand 1996; 40:520-3. [copyright sign] 1996 Munksgaard International Publishers Ltd., Copenhagen, Denmark.Eriksson et al. [35] hypothesized that the underlying mechanism of this HVR depression was caused by an interaction with hypoxic chemosensitivity of the carotid bodies. In the anesthetized rabbit, it was later shown that injection of small doses of a muscle relaxants into the carotid body via a lingual artery catheter caused a dose-dependent depression of the phrenic nerve activity during systemic hypoxia [37]. Wyon et al. [38] also showed in vivo that the firing frequencies of single isolated chemoreceptors in the carotid body were almost abolished by the systemic administration of vecuronium (Figure 5). After vecuronium doses of 0.15 mg/kg body weight, the depressed chemoreceptor recovered spontaneously, and complete recovery was achieved after 90-120 min.Figure 5: The relationship between chemoreceptor activity and PaO2 in a single carotid body chemoreceptor after systemic administration of vecuronium to a rabbit. Original hyperbolic plot (chemoreceptor output = a + b(PaO2)-1. Chemoreceptor response curves during control and after the administration of 0.1 and 0.5 mg of vecuronium IV are presented. Data from Wyon et al. [38] and Figure reprintedwith permission from Anesthesiology.Thus, there is evidence from both early in vitro experiments [27,29,31,32] and from recent human and animal studies [34-38] that nondepolarizing neuromuscular blocking drugs interfere with hypoxic ventilatory control. In anesthetic practice, this is a new and hitherto unknown property of these drugs. The mechanism behind this interaction seems to be a spontaneously reversible depression of carotid body chemoreceptor activity during hypoxia. Although a cholinergic receptor inhibition seems most likely, the exact nature of this interaction with the chemoreceptor remains to be clarified. In addition, it is not known whether this interaction can be reversed by the administration of an anticholinesterase drug. The significance of this interference should be considered. Depressed hypoxic ventilatory responses during partial neuromuscular block has been described among awake and healthy volunteers to whom no other sedative or hypnotic drugs have been given. Obviously, the postoperative patient most likely has residual levels of other anesthetics, such as IV opioids, hypnotics and/or inhaled anesthetics. In the presence of a partial neuromuscular block, the postoperative patient may therefore have further depression of ventilation. In addition, when conducting animal experiments, the depression of chemoreceptor activity may have important implications for interpretation of previous experimental work in the field of carotid body chemoreceptor function. In many studies, muscle relaxants have been administered as intermittent bolus doses or continuous infusions as a part of the anesthetic procedure to keep the animal immobilized. The possibility that this anesthetic technique may have interfered with normal chemoreceptor function and thus, with the results of the experiment, should be kept in mind. Hence, these findings have implications not only for daily patient care, but also for experimental practice concerning ventilatory studies. Residual Effects of Volatile Anesthetics and Hypoxic Ventilatory Control Volatile anesthetics are associated with a dose-dependent depression of minute ventilation, which is due to changes in both tidal volume and respiratory frequency. The reduced minute ventilation is caused by a reduction of tidal volumes that is relatively greater than the simultaneous increase in respiratory frequency [39,40]. Thus, the alveolar minute ventilation is reduced, which is followed by an increase in arterial carbon dioxide tension. As a consequence, the ventilatory response and sensitivity to carbon dioxide are reduced [39,40]. Human Studies The effects on hypoxic ventilatory control by volatile inhaled anesthetics are controversial. Knill and Gelb [41], Knill et al. [42], and Gelb and Knill [43] presented a series of investigations that identified the effects of sedative and anesthetic concentrations of these drugs on hypoxic ventilatory control. Based on their findings, it was concluded that volatile inhaled in both anesthetic [41] and subanesthetic concentrations [42,43], caused a pronounced depression of peripheral hypoxic chemosensitivity. This has subsequently been the general opinion in anesthesia literature [44,45]. A series of conflicting findings have been published in which different groups of researchers using somewhat different methodologies have found either a markedly depressed acute hypoxic ventilatory response during subanesthetic concentrations of inhaled anesthetics [46,47] or relatively well maintained hypoxic ventilatory responses [48-52]. Hence, there is disagreement regarding the influence of small-dose inhaled anesthetics on the hypoxic chemosensitivity, that is, on the peripheral chemoreception. In 1994, two editorials [53,54] addressed this controversy and stated independently that the conflicting results of human experiments by Knill and Gelb [41], Knill et al. [42], Gelb and Knill [43], Dahan et al. [46], and van den Elsen et al. [47] to those of Temp et al. [48,49] and Sjogren et al. [50,51] most likely were due to different states of consciousness (eyes open versus eyes closed, awake, versus asleep) or methodological differences (e.g., hypercapnia versus normocapnia versus poikilocapnia). Moreover, minor variations in terminology added to the disagreement among research groups. For instance, in the studies by Dahan et al. [46], van den Elsen et al. [47], and others [55], the method focused on effects on the "peripheral chemoreflex loop," rather than the peripheral chemoreceptor per se, which is any effect arising in the event chain from the carotid body chemoreceptor, via the afferent sinus nerve/glossopharyngeal nerve, into the respiratory integrator located in the brainstem. This imaginary functional structure is determined by mathematical modeling; that is, the dynamic acute hypoxic response is divided into a fast component (the peripheral response) and a slow component (the central response). Any effect found by this modeling in the peripheral response was attributed to the peripheral chemoreceptors. The term "reflex loop" illustrates that the technique does not directly measure the function of the peripheral chemoreceptor but rather indirectly measures the noncentral contribution to hypoxic ventilation. The technique has been validated in cats [56]. As mentioned above, there is a consensus that volatile anesthetics have a dose-dependent depressant effect on the CNS [39,40], including respiratory neurons within the brainstem [57-59]. Therefore, it must be expected that all inhaled anesthetics have a dose-dependent depressant effect on the ventilatory control during both hypoxia and hypercapnia, even if some key components in the oxygen sensing system may be intact. There are limitations to how close an investigator can come to the peripheral oxygen sensor as long as human studies are evaluated. Most studies have been performed in human volunteers or patients in whom minute ventilation and changes in minute ventilation have been used to indirectly estimate effects of inhaled anesthetics on hypoxic ventilatory control, sometimes with advanced mathematical modeling (see above). The experimental conditions have also varied. Some studies have used hypercapnia with resting ventilation >10 L/min during recording of isocapnic hypoxic ventilatory responses [41-43,46,47], whereas others have used normocapnia or poikilocapnia for the same procedure with resting ventilation <10 L/min [50-52]. Because of the profound interaction between inhaled anesthetics and central carbon dioxide chemosensitivity, the various methods cannot be expected to yield similar results. This is illustrated by the study of Dahan et al. [60] during desflurane anesthesia in which a ventilatory depression was found during hypercapnic isocapnia whereas no depression was found during normocapnic isocapnia. In other studies in which the consciousness of the subjects varied, similar interpretational problems have occurred [53,54]. If the varying methods and their results are being compared, it is clear that the state of consciousness and/or level of carbon dioxide tension have a pronounced influence on whether a depression of the hypoxic ventilatory control during subanesthetic levels of inhaled anesthetics has been found. Finally, it should be remembered that, normally, patients respond to hypoxia with a poikilocapnic ventilatory response. Hence, in reviewing human studies, the acute hypoxic ventilatory response is depressed but still present during inhaled anesthesia, the magnitude of the depression being dose-dependent. Robotham [53] and Goodman [54] also raise the question of whether the depression of ventilation during hypoxia is of clinical importance. Although Robotham [53] stated that even at 0.1 minimum alveolar anesthetic concentration there may be a clinically important depression, Goodman argued that this depression is of limited importance because patients in the recovery room most likely have CO (2) levels sufficient to drive ventilation. Instead, he believes that the major risk during recovery from anesthesia is from obstruction of the airway, not from ventilatory depression. However, the possible interaction between inhaled anesthetics and other anesthetic drugs, such as hypnotics (e.g., bensodiazepines) and opioids, must be considered when discussing the clinical importance of ventilatory depression in the recovery room. Hence, any depression of ventilation by a single anesthetic drug should be regarded as unwanted in the recovery room. Animal Studies When focusing the question on whether there is a direct depressant effect by inhaled anesthetics on the chemoreceptor, animal studies have yielded data that are more uniform than human data, because similar findings have been described in various species and among various researchers [61-64]. Van Dissel et al. [62] and Gaudy et al. [63] did not find any evidence of a depressant effect by inhaled anesthetics on the peripheral chemoreceptor. The hypothesis was also tested by Koh and Severinghaus [61] in the spontaneously breathing goat during halothane anesthesia. They found an increase in minute ventilation during hypoxic challenge that was minimally reduced at 0.5% (end-tidal) halothane anesthesia compared with awake control response and a further dose-dependent reduction during deeper halothane anesthesia (1.2% end-tidal halothane). Interestingly, similar findings have been shown by Sollevi and Lindahl [52] in humans during subanesthetic and anesthetic levels of isoflurane. Hence, these findings in two different species (Figure 6) speak against conclusions made by Knill and Gelb [41], Knill et al. [42], Gelb and Knill [43], and others [46,47,55] about peripheral chemosensitivity and show that there is a hypoxic ventilatory response present even at anesthetic levels of inhaled anesthetics. Furthermore, similar findings were reported by Stuth et al. [59] who demonstrated a phrenic nerve response to hypoxia in the anesthetized dog (Figure 7). Although the overall phrenic nerve activity was markedly depressed during hypoxia, the relationship between resting activity and the activity during hypoxia was unchanged during deep halothane anesthesia. In addition, chemoreceptor denervation caused an abolished ventilatory response to hypoxia, which confirmed that the recorded hypoxic ventilatory response during anesthesia originated from the carotid body chemoreceptors (Figure 8). Hence, it is clear that the peripheral chemoreceptors were activated by hypoxia during inhaled anesthesia.Figure 6: Lack of species differences between isocapnic hypoxic ventilatory responses during halothane and isoflurane anesthesia in an animal model and in humans. Data redrawn from Koh and Severinghaus [61] and from Sollevi and Lindahl [52]. There was an increase in ventilation during isocapnic hypoxia that is of the same magnitude in goats and humans, comparing control ventilation with hypoxic challenges during subanesthetic levels of inhaled anesthesia (halothane 0.5% and isoflurane 0.2%), which indicates that the peripheral chemoreception is intact. Moreover, the the dose-dependent reduction in hypoxic ventilatory responses during inhaled anesthesia (halothane and isoflurane > 1.0%) is comparable in these two. Data shown with permission from Koh SO, Severinghaus JW. Effect of halothane on hypoxic and hypercapnic ventilatory responses of goats. Br J Anaesth 1990;65:713-7. (by permission of Oxford University Press) and Sollevi A, Lindahl SGE. Hypoxic and hypercapnic ventilatory responses during isoflurane and in Acta Scand [copyright sign] Munksgaard International Publishers Ltd., Copenhagen, Effect of halothane concentration on phrenic nerve activity during hypercapnic control states and for hypoxic were to the control at 1 minimum alveolar concentration = increase due to hypoxia compared with control. P < halothane dose-dependent for the hypercapnic control compared with the sign] = P < From Stuth et al. [59] and Figure reprintedwith permission from nerve responses to acute isocapnic hypoxia and after carotid body chemoreceptor denervation during 1 minimum alveolar concentration halothane anesthesia during hypoxic challenge airway The increase in phrenic nerve during hypoxia was which indicates that the response is by the carotid body chemoreceptors. the of any depressant effect of hypoxia in the From Stuth et al. [59] and with permission from the effect of volatile inhaled anesthetics on carotid body chemoreceptors has been directly in various In and showed that halothane did not the chemoreceptor activity during hypoxia at PaO2 as recorded from the sinus nerve et al. chemoreceptor in the and found a depression during anesthetic whereas and inhaled anesthetics and their direct effects on the chemoreceptor function during normocapnic hypoxic challenges in both cat and using a single chemoreceptor They found a minor chemoreceptor depression PaO2 > whereas no depression was found at PaO2 < Interestingly, these experiments the administration of a continuous of nondepolarizing neuromuscular blocking drugs to keep the animals immobilized. In the rabbit, et al. the effects of isoflurane on chemoreceptor during hypoxia at either or hypercapnia, the administration of a muscle The chemoreceptor activity was unchanged during isoflurane anesthesia, of the underlying arterial carbon dioxide tension (Figure Thus, the similar findings has been from a of species rabbit, and and there is no to that it should be different in humans Hence, the chemosensitivity of the carotid body chemoreceptor seems not to be by volatile inhaled anesthetics. The depression of HVR during anesthesia must therefore within the The carotid body chemoreceptor activity during control state isoflurane and during administration of (end-tidal) isoflurane at normocapnia the lack of depression of the chemoreceptor activity during isoflurane anesthesia. Data from et al. and with permission from Eriksson Lindahl et al. The effect of isoflurane on peripheral chemoreceptor sensitivity to varying and Acta Scand [copyright sign] Munksgaard International Publishers Ltd., Copenhagen, residual effects of neuromuscular blocking drugs and inhaled anesthetics interfere with ventilatory control in the postoperative states by different doses of neuromuscular blocking drugs resting minute ventilation because a reduction in respiratory tidal volumes is by an increase in respiratory due to maintained carbon dioxide In contrast, the hypoxic ventilatory control is depressed due to an interaction with the carotid body chemoreceptors, most likely on an interaction with cholinergic of the carotid bodies. an adductor pollicis TOF ratio of the pharyngeal function is in a to increase in the risk of aspiration. anesthetics, however, a dose-dependent reduction of resting ventilation and minute ventilation during hypercarbia and hypoxia due to a general depression of central control, including the respiratory neurons of the brainstem. The hypoxic chemosensitivity of the carotid body chemoreceptors, however, are minimally affected by inhaled anesthetics, even at anesthetic levels of the Residual neuromuscular block impaired of ventilation during hypoxia and impaired pharyngeal function and airway and it is a risk factor for the of postoperative pulmonary normal muscle function and normal ventilatory an adductor pollicis TOF ratio of should be achieved a patient is to spontaneously after tracheal This can only be using monitoring of neuromuscular such as or anesthetics ventilation at anesthetic and subanesthetic The carotid body chemoreceptor function is, however, well maintained at subanesthetic end-tidal concentrations of volatile inhaled anesthetics.
No takes yet. Share an insight, caveat, or question.
Lars I. Eriksson (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: